Blog

You are currently viewing Can Mild Cognitive Impairment Be Reversed?
Can Mild Cognitive Impairment be reversed? Increasing evidence and the EVANTHEA Precision Medicine study suggest that improvement is possible for many patients.

Can Mild Cognitive Impairment Be Reversed?

Can Mild Cognitive Impairment Be Improved?

Yes. Mild Cognitive Impairment (MCI) can improve, and in many cases substantial improvement is possible. That statement surprises many people because patients have been told for decades that memory loss is progressive. And, it’sirreversible, and something to simply monitor over time.

However, the science of Precision Medicine, neuroplasticity, and the EVANTHEA Precision Medicine Trial suggest that this older view is incomplete. Mild Cognitive Impairment should not automatically be viewed as a one-way road toward dementia or Alzheimer’s disease.

At the Carroll Institute in Sarasota, Florida, we believe the most important question is not simply, “Can MCI improve?” The better question is: why is this brain struggling, and what can be done to help it function better?

Why This Question Matters

Receiving a diagnosis of Mild Cognitive Impairment can be frightening. Many people immediately wonder whether they are developing Alzheimer’s disease, whether their memory will continue to worsen, and whether anything can be done to change the outcome.

For many years, the answer patients received was discouraging. They were often told to monitor their symptoms, come back for repeat testing, and prepare for possible progression.

That approach may be appropriate in some settings, but it often leaves out the most important question: what is causing the cognitive decline?

MCI is a diagnosis. It is not a root cause. Therefore, the diagnosis should be the beginning of the investigation, not the end of the conversation.

Why Patients Were Told MCI Could Not Improve

Traditionally, cognitive decline was viewed through a narrow lens. Once memory problems appeared, many patients were told that the decline would likely continue. In that model, the goal was not improvement. The goal was simply to slow progression.

That belief developed partly because conventional Alzheimer’s treatments have produced limited clinical results. Some medications may modestly slow decline in selected patients, but they do not restore lost memory or return the brain to its previous level of function.

As a result, many patients came to believe that improvement was not realistic.

Fortunately, modern Precision Medicine challenges that assumption. Instead of asking only how to slow decline, Precision Medicine asks why the brain is declining in the first place.

What the EVANTHEA Precision Medicine Trial Changed

The EVANTHEA Precision Medicine Trial represents an important shift in the treatment of cognitive decline. Rather than focusing on a single drug or one biological target, the study evaluated and addressed multiple contributors affecting brain health.

These contributors included areas such as inflammation, metabolic health, sleep, nutrition, exercise, stress, hormonal balance, and cognitive stimulation.

Most importantly, participants demonstrated improvement in cognitive measures during the study period. That matters because improvement is very different from simply slowing decline.

This does not mean every patient will respond in the same way. No ethical clinician can guarantee a specific outcome. However, the EVANTHEA study supports a much more hopeful and more realistic message: when the factors contributing to cognitive decline are identified and addressed, meaningful improvement may be possible.

MCI and Early Alzheimer’s Disease Should Be Discussed Together

Many patients wonder whether this discussion applies only to MCI or whether it also applies to early Alzheimer’s disease.

At the Carroll Institute, we often discuss MCI and early Alzheimer’s disease together because the underlying contributors may be very similar. The label may change, but the core question remains the same:

Why is this brain struggling?

Whether a patient has Mild Cognitive Impairment, early Alzheimer’s disease, memory loss, or progressive cognitive decline, the same root-cause investigation is often essential.

Neuroplasticity: The Brain’s Hidden Advantage

One of the most important reasons improvement is possible is neuroplasticity.

Neuroplasticity is the brain’s ability to adapt, reorganize, strengthen existing pathways, and build new connections. For many years, scientists believed the adult brain was relatively fixed. We now know that is not true.

The brain can change throughout life. It can learn, adapt, and strengthen pathways through targeted stimulation and repetition.

At the Carroll Institute, we often describe neuroplasticity as a turbocharger for Precision Medicine. Precision Medicine identifies the factors interfering with brain health. Functional Neurology helps stimulate the brain networks that need rehabilitation.

When those two ideas work together, patients may have more opportunity for improvement than they have been told.

Why Root Causes Matter

Mild Cognitive Impairment does not usually develop for one single reason. In many patients, several factors are affecting the brain at the same time.

Common contributors may include:

  • Chronic inflammation
  • Insulin resistance
  • Sleep apnea or poor sleep quality
  • Vascular dysfunction
  • Hormonal imbalances
  • Nutritional deficiencies
  • Mold exposure
  • Heavy metals or environmental toxins
  • Chronic stress
  • Brain network dysfunction

Because every patient has a different combination of contributors, every patient requires a different strategy. This is why one-size-fits-all approaches often produce disappointing results.

Why Timing Matters

Earlier action usually creates more opportunities.

That does not mean patients with more advanced cognitive decline cannot improve. Many still can. However, the earlier the contributing factors are identified, the more brain reserve and neuroplasticity may remain available.

Waiting rarely creates additional options. In contrast, early investigation can reveal opportunities that might otherwise be missed.

Why Patient Participation Matters

Precision Medicine is not passive care. It requires participation.

Depending on the patient, improvement may require changes in nutrition, sleep, exercise, stress management, supplementation, cognitive rehabilitation, and follow-up testing.

This is not always easy. However, patients who fully engage with the process often create more opportunities for improvement than those who only partially participate.

The goal is not perfection. The goal is consistency.

The Carroll Cognitive Method™ Perspective

The Carroll Cognitive Method™ was developed around a simple but powerful idea: cognitive decline is usually a systems problem, not a single-target problem.

The method combines three key disciplines:

Precision Medicine

Precision Medicine identifies the unique biological contributors affecting each patient’s brain health.

Functional Medicine

Functional Medicine addresses root causes such as inflammation, insulin resistance, sleep problems, nutritional deficiencies, hormonal imbalances, and environmental exposures.

Functional Neurology

Functional Neurology evaluates how the brain is functioning and uses targeted rehabilitation strategies to support neuroplasticity and brain network performance.

Together, these disciplines allow us to ask a better question than “How do we slow decline?”

We ask: what is preventing this brain from improving?

Hope Without False Promises

Can Mild Cognitive Impairment be improved?

Yes.

In many cases, substantial improvement is possible when the right contributors are identified and addressed. At the same time, every patient is different. Trauma, severe vascular insufficiency, advanced neurodegeneration, poor compliance, and other medical factors may affect outcomes.

That is why no responsible clinician should promise that every person will improve in the same way.

Still, the old message that MCI is simply something to monitor is no longer enough.

Patients deserve a deeper investigation. They deserve a more hopeful conversation. Most importantly, they deserve a plan that looks for the reasons their brain is struggling.

Next Steps

Mild Cognitive Impairment should not be dismissed as normal aging. It should also not be viewed automatically as inevitable decline.

The better question is not simply whether MCI can improve.

The better question is:

What factors are preventing this particular brain from improving?

If you or someone you love has been diagnosed with Mild Cognitive Impairment, early Alzheimer’s disease, or worsening memory problems, the Carroll Institute can help you explore whether the Carroll Cognitive Method™ may be appropriate for you.

Sources

Medical Disclaimer

This information is provided for educational purposes only and is not intended as medical advice. Individual outcomes vary. No specific result can be guaranteed. Patients should consult a qualified healthcare professional regarding their individual medical situation.

Reviewed by: Dr. Garland Glenn, DC, PhD, IFM, AFMC

Location: Sarasota, Florida

Last Updated: June 19, 2026

Dr. Garland Glenn, DC, PhD, IFM, AFMC

Founder & Clinical Director, The Carroll Institute — Sarasota, FL

Dr. Garland Glenn is a board-certified chiropractic physician and functional medicine practitioner specializing in cognitive health, neurodegeneration, and root-cause medicine. Certified as an AFMC (Advanced Functional Medicine Clinician) and Institute for Functional Medicine (IFM) trained. He has also completed over 500 hours of advanced training in Functional Neurology under Dr. Ted Carrick, founder of the Carrick Institute.

At The Carroll Institute, Dr. Glenn leads Sarasota’s only ReCODE-certified Functional Neurology program, helping patients reverse or prevent cognitive decline through the Bredesen ReCODE Protocol, neuroplasticity exercises, and personalized functional medicine care.

Learn more about his background and approach at About Dr. Garland Glenn.

– schedule now –

free discovery call

To help you get started, we offer a free 20-minute Discovery Phone Consultation. During this call, you will be able to talk with one of our Certified Brain Health Coaches about what going on with you or your loved one and find out if we can help. Please review our FAQs prior to scheduling your free call. We look forward to talking with you soon and helping you Save Your Brain.

Let's get started

(yes, it’s totally free!)

ReCODE® is a registered program developed by Dr. Dale Bredesen and licensed through Apollo Health. Dr. Garland Glenn is a certified ReCODE practitioner.

Tags: , , , , , , ,